These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12615884)

  • 1. In vitro activity of fluoroquinolones against erythromycin-susceptible and -resistant Bordetella pertussis.
    Bourgeois N; Ghnassia JC; Doucet-Populaire F
    J Antimicrob Chemother; 2003 Mar; 51(3):742-3. PubMed ID: 12615884
    [No Abstract]   [Full Text] [Related]  

  • 2. Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis.
    Lewis K; Saubolle MA; Tenover FC; Rudinsky MF; Barbour SD; Cherry JD
    Pediatr Infect Dis J; 1995 May; 14(5):388-91. PubMed ID: 7638015
    [No Abstract]   [Full Text] [Related]  

  • 3. Where macrolide resistance is prevalent.
    Li Y; Liu X; Zhang B; He Q; Wang Z
    APMIS; 2015 Apr; 123(4):361-3. PubMed ID: 25703275
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Nov; 43(44):807-10. PubMed ID: 7968996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the Centers for Disease Control and Prevention. Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994.
    JAMA; 1995 Jan; 273(1):13-4. PubMed ID: 7996637
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct Detection of Erythromycin-Resistant Bordetella pertussis in Clinical Specimens by PCR.
    Wang Z; Han R; Liu Y; Du Q; Liu J; Ma C; Li H; He Q; Yan Y
    J Clin Microbiol; 2015 Nov; 53(11):3418-22. PubMed ID: 26224847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying antibiotic treatment strategies in the face of pertussis surge associated to erythromycin resistance in China.
    Shi W; Meng Q; Hu Y; Yao K
    J Infect; 2024 Jun; 88(6):106174. PubMed ID: 38719109
    [No Abstract]   [Full Text] [Related]  

  • 8. Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance.
    Wilson KE; Cassiday PK; Popovic T; Sanden GN
    J Clin Microbiol; 2002 Aug; 40(8):2942-4. PubMed ID: 12149356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin for pertussis: probable reasons for past failures.
    Bass JW
    Lancet; 1985 Jul; 2(8447):147. PubMed ID: 2862331
    [No Abstract]   [Full Text] [Related]  

  • 10. High prevalence of erythromycin-resistant Bordetella pertussis in Xi'an, China.
    Wang Z; Cui Z; Li Y; Hou T; Liu X; Xi Y; Liu Y; Li H; He Q
    Clin Microbiol Infect; 2014 Nov; 20(11):O825-30. PubMed ID: 24816168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of erythromycin and amoxycillin on Bordetella pertussis in the nasopharynx.
    Trollfors B
    Infection; 1978; 6(5):228-30. PubMed ID: 215555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones.
    Hoppe JE; Simon CG
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2287-8. PubMed ID: 2073123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient.
    Yao SM; Liaw GJ; Chen YY; Yen MH; Chen YH; Mu JJ; Chiang CS
    J Med Microbiol; 2008 Dec; 57(Pt 12):1577-1580. PubMed ID: 19018032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levofloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem.
    Hoppe JE; Rahimi-Galougahi E; Seibert G
    Antimicrob Agents Chemother; 1996 Mar; 40(3):807-8. PubMed ID: 8851619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution melting analysis for the detection of two erythromycin-resistant Bordetella pertussis strains carried by healthy schoolchildren in China.
    Zhang Q; Li M; Wang L; Xin T; He Q
    Clin Microbiol Infect; 2013 Jun; 19(6):E260-2. PubMed ID: 23480481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin for treatment and prevention of pertussis.
    Bass JW
    Pediatr Infect Dis; 1986; 5(1):154-7. PubMed ID: 2868449
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro activity of gemifloxacin and other antimicrobial agents against isolates of Bordetella pertussis and Bordetella parapertussis.
    Mortensen JE; Rodgers GL
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():47-9. PubMed ID: 10824032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemic of erythromycin-resistant
    Yao K; Deng J; Ma X; Dai W; Chen Q; Zhou K; Ye J; Shi W; Wang H; Li D; Wang H; Wang J; Zhang J; Wu D; Xie G; Shen K; Zheng Y; Yang Y
    Expert Rev Vaccines; 2020 Nov; 19(11):1093-1099. PubMed ID: 33034224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of antimicrobial resistance in contemporary clinical isolates of Bordetella pertussis in Ontario, Canada.
    Marchand-Austin A; Memari N; Patel SN; Tang P; Deeks SL; Jamieson FB; Crowcroft NS; Farrell DJ
    Int J Antimicrob Agents; 2014 Jul; 44(1):82-4. PubMed ID: 24837412
    [No Abstract]   [Full Text] [Related]  

  • 20. Co-infection with two different strains of Bordetella pertussis in an infant.
    Cassiday PK; Tobin-D'Angelo M; Watson JR; Wu KH; Park MM; Sanden GN
    J Med Microbiol; 2008 Mar; 57(Pt 3):388-391. PubMed ID: 18287306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.